Home > Insider Trading > Filing (0001384101-19-000124)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1384101	Veracyte Inc.	VCYT	Services-Medical Laboratories (8071)	205455398

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1781127	Jr Walter John Hanna	6000 Shoreline Court Suite 300 South San Francisco CA 94080	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-16	18,593	$5.98	84,085	No	4	M	Direct
Common Stock	Disposition	2019-09-16	18,593	$25.66	65,492	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2019-09-16	18,593	$0.00	18,593	$5.98

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
33,907		2028-03-01	No	4	M	Direct

Footnotes

The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019.
Represents weighted average sales price. Sale prices for the transactions range from $25.21 to $26.04. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.